HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Human Leukocyte Antigen Locus and Rheumatic Heart Disease Susceptibility in South Asians and Europeans.

Abstract
Rheumatic heart disease (RHD), an autoinflammatory heart disease, was recently declared a global health priority by the World Health Organization. Here we report a genome-wide association study (GWAS) of RHD susceptibility in 1,163 South Asians (672 cases; 491 controls) recruited in India and Fiji. We analysed directly obtained and imputed genotypes, and followed-up associated loci in 1,459 Europeans (150 cases; 1,309 controls) from the UK Biobank study. We identify a novel susceptibility signal in the class III region of the human leukocyte antigen (HLA) complex in the South Asian dataset that clearly replicates in the Europeans (rs201026476; combined odds ratio 1.81, 95% confidence intervals 1.51-2.18, P = 3.48×10-10). Importantly, this signal remains despite conditioning on the lead class I and class II variants (P = 0.00033). These findings suggest the class III region is a key determinant of RHD susceptibility offering important new insight into pathogenesis while partly explaining the inconsistency of earlier reports.
AuthorsKathryn Auckland, Balraj Mittal, Benjamin J Cairns, Naveen Garg, Surendra Kumar, Alexander J Mentzer, Joseph Kado, Mai Ling Perman, Andrew C Steer, Adrian V S Hill, Tom Parks
JournalScientific reports (Sci Rep) Vol. 10 Issue 1 Pg. 9004 (06 02 2020) ISSN: 2045-2322 [Electronic] England
PMID32488134 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA Antigens
Topics
  • Asian People (genetics)
  • Case-Control Studies
  • Fiji
  • Genetic Predisposition to Disease
  • Genome-Wide Association Study
  • HLA Antigens (genetics)
  • Humans
  • India
  • Polymorphism, Single Nucleotide
  • Rheumatic Heart Disease (genetics)
  • White People (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: